
The American Society of Hematology (ASH) has released new guidelines for diagnosing iron deficiency, recommending higher serum ferritin thresholds for various groups. These guidelines aim to identify iron deficiency earlier, even in those without anemia. The recommendations were developed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework, ensuring a structured and evidence-based approach.
Published in Blood Advances, the guidelines were developed by a multidisciplinary panel led by Jacquelyn M. Powers of Baylor College of Medicine. The panel addressed the lack of consistent, evidence-based recommendations for diagnosing iron deficiency, the most common micronutrient deficiency. Evidence reviews examined the prevalence of iron deficiency across populations and studies evaluating diagnostic thresholds through July 2025, ensuring the guidelines are grounded in the latest research.
Higher Thresholds for Broader Detection
For children aged 9 months to 4 years, the recommended threshold is now ≤20 ng/mL, up from ≤12 ng/mL. This change aims to capture iron deficiency earlier in this vulnerable age group. For non-menstruating adolescents, a threshold of ≤30 ng/mL is proposed, providing a more subtle approach to diagnosis.
For adults who are neither menstruating nor pregnant, the new threshold is ≤30 ng/mL, replacing the previous ≤15 ng/mL. A higher threshold of ≤50 ng/mL may be used for those with symptoms or risk factors, allowing for better identification of at-risk individuals. These adjustments reflect the panel’s consideration of clinical impact, patient preferences, and resource requirements.
Specific Recommendations for At-Risk Groups
The guidelines offer tailored advice for menstruating individuals, suggesting a threshold of ≤30 ng/mL and recommending against the lower ≤15 ng/mL. For those with heavy menstrual bleeding or other risk factors, a threshold of ≤50 ng/mL may be appropriate. Additionally, a detailed menstrual history is recommended when evaluating abnormal or heavy bleeding, ensuring a full assessment.
Read Also: Cardiac patients feel unprepared for complications
For pregnant individuals, the suggested threshold is also ≤30 ng/mL, with ≤50 ng/mL considered for those with anemia, regardless of additional risk factors. This approach ensures timely intervention to prevent complications during pregnancy.
Dual Testing for Inflammatory Conditions
In cases of anemia of inflammation, ASH recommends measuring both serum ferritin and transferrin saturation (TSAT) instead of relying on ferritin alone. Iron deficiency is indicated when TSAT is below 20% or ferritin is below 100 ng/mL. TSAT should preferably be measured after a 5- to 9-hour fast, including avoidance of multivitamin or iron supplements during the fasting period, to ensure accurate results.
This approach is particularly relevant for conditions like inflammatory bowel disease, cancer, and chronic kidney disease. The panel emphasizes that iron deficiency can coexist with other causes of anemia, especially in inflammatory conditions. Interpretation of ferritin and TSAT results should consider the patient’s history, examination, underlying disease, and relevant disease-specific guidance.
The guidelines acknowledge limitations, including low certainty of evidence for some recommendations and insufficient data for certain populations, such as children with inflammation. Further research is needed to refine diagnostic criteria and address these gaps.
